Publications by authors named "Kevin Schaab"

Claim this Profile
C
Crystal Nucleation Using Surface-Energy-Modified Glass Substrates.
Kyle A Nordquist, Kevin M Schaab, Jierui Sha, Andrew H Bond

Cryst Growth Des· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamics, pharmacokinetics and safety of GSK2190915, a novel oral anti-inflammatory 5-lipoxygenase-activating protein inhibitor.
Gretchen Bain, Christopher D King, Kevin Schaab, Melissa Rewolinski, Virginia Norris

Br J Clin Pharmacol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-Lipoxygenase-activating protein inhibitors. Part 3: 3-{3-tert-Butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5-methyl-pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM643)-A potent FLAP inhibitor suitable for topical administration.
Nicholas Stock, Christopher Baccei, Gretchen Bain, Charles Chapman, Lucia Correa, Kevin Schaab

Bioorg Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis